Related Experiment Video

Updated: May 28, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

[Genetic and genomic studies in the hypertension: an actualization of the genomic studies]

Julián Ramírez-Bello1, Oscar Pérez-Méndez, Silvestre Ramírez-Fuentes

  • 1Laboratorio de Inmunogenómica y Enfermedades Metabólicas, Instituto Nacional de Medicina Genómica. México, D. F.

Archivos De Cardiologia De Mexico
|October 7, 2011
PubMed

Insights

Arterial hypertension, a major risk factor for cardiovascular diseases, has complex genetic and environmental causes. This review identifies key genes contributing to hypertension susceptibility worldwide and in Mexico.

Area of Science:

  • Cardiovascular Medicine
  • Genetics and Genomics
  • Public Health

Context:

  • Arterial hypertension is a leading global risk factor for cardiovascular diseases, including myocardial infarction and heart failure.
  • Cardiovascular diseases account for millions of deaths worldwide, with hypertension projected to be the leading cause of death.
  • In Mexico, hypertension affects approximately 30.8% of adults, representing a significant public health challenge.

Purpose:

  • To review and compare global and Mexican studies on the genetics and genomics of arterial hypertension.
  • To identify specific genes and genetic loci associated with hypertension susceptibility.
  • To synthesize current knowledge on the molecular and genetic mechanisms underlying hypertension.

Summary:

  • Arterial hypertension is a multifactorial condition influenced by genetic, environmental, gender, and ethnic factors.
  • Despite its prevalence and impact, the precise molecular and genetic mechanisms of hypertension remain incompletely understood.
  • Advances in genomic analysis have identified several susceptibility genes for hypertension.

Impact:

  • This review provides a comprehensive overview of genetic factors contributing to hypertension.
  • Identifying key genes can inform targeted prevention and treatment strategies for hypertension.
  • Understanding the genetic basis of hypertension is crucial for reducing cardiovascular disease burden globally and in Mexico.

More Related Videos

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats10:28

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta08:08

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta

Published on: June 10, 2015

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...